Home - Products - Others - Other Targets - 1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-

1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-

CAS No. 87095-86-1

1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-( ——— )

Catalog No. M39807 CAS No. 87095-86-1

1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 Get Quote
10MG 656 Get Quote
25MG 1026 Get Quote
50MG 1386 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-
  • Description
    1-Propanone,1-(4-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    87095-86-1
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isoarboreol

    Isoarboreol

  • Thymus peptide C

    Thymus peptide C, a hormonal drug derived from the thymus glands of young calves, acts as a substitute for the physiological functions of the thymus.

  • PAR-3 (1-6) (human)

    PAR3 (1-6) is a synthetic peptide agonist of proteinase-activated receptor 1 (PAR1) that corresponds to residues 1-6 of the amino terminal tethered ligand sequence of human PAR3 and residues 39-44 of the full-length human sequence. PAR3 (1-6) activates p42/44 MAPK signaling in fibroblasts expressing PAR1, but not PAR3, an effect that can be blocked by the PAR1 antagonist RWJ 56110.